Evid Based Nurs 13:23-24 doi:10.1136/ebn1024
  • Therapeutics
  • Systematic review

Neuraminidase inhibitors produce a small reduction in duration of seasonal flu in children and reduce transmission in affected households, but effects on serious complications are unclear

  1. Claire Waddington
  1. Oxford Vaccine Group, University of Oxford, UK
  1. Correspondence to Karen J Ford
    Oxford Vaccine Group, Clinical Centre for Vaccinology and Tropical Medicine, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LJ, UK;{at}

Commentary on:

This review addresses the use of antiviral medication in the treatment and prophylaxis of seasonal flu in children. This issue is especially relevant given the current pandemic, in which children have experienced high disease rates and the highest hospitalisation rates.1,,3 This review supplements the 2007 Cochrane review4 and is specific to paediatric patients, consolidating information from reviews focusing on adults.5

The article is a review and meta-analysis of randomised controlled trials of neuraminidase inhibitors in children aged <12 years in the community with either confirmed or clinically suspected flu. A comprehensive search for relevant trial data included electronic databases (Medline and Embase). Primary outcome measures were time to resolution of illness or the incidence …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article